Donor-Derived Transmission of Hepatitis C in a Hepatitis C-Naive Heart Transplant Recipient Treated with a Pan-Genotypic Agent: Viral Kinetics and Implications for Expanded Donor Availability

被引：0
|
作者：
Sam, T. [1 ]
Wada, S. [2 ]
Joseph, S. M. [3 ]
Trotter, J. F. [1 ]
Asrani, S. K. [1 ]
Lima, B. [3 ]
Gonzalez-Stawinski, G. [3 ]
Hall, S. A. [3 ]
Gottlieb, R. L. [3 ]
机构：
[1] Baylor Univ, Med Ctr, Baylor Annette C & Harold C Simmons Transplant In, Dallas, TX USA
[2] Baylor Univ, Med Ctr, Transplant Infect Dis, Dallas, TX USA
[3] Baylor Univ, Med Ctr, Baylor Ctr Adv Heart & Lung Dis, Dallas, TX USA
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2017年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
186
引用
收藏
页码：S79 / S79
页数：1
相关论文
共 25 条
  • [21] A Pilot Trial for Prevention of Hepatitis C Virus Transmission From Donor to Organ Transplant Recipient With Short-Course Glecaprevir/Pibrentasvir
    Ramirez-Sanchez, Claudia
    Kozuch, Jade
    Shah, Mita M.
    Berumen, Jennifer
    Mekeel, Kristin
    Schnickel, Gabriel
    Taremi, Mahnaz
    Golts, Eugene
    Afshar, Kamyar
    Adler, Eric
    Pretorius, Victor
    Aslam, Saima
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (11):
  • [22] Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient
    Campos-Varela, Isabel
    Agudelo, Eliana Z.
    Sarkar, Monika
    Roberts, John P.
    Terrault, Norah A.
    TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (01)
  • [23] Anti-erythropoietin antibody-mediated pure red cell aplasia in a living donor liver transplant recipient treated for hepatitis C virus
    Schecter, Jordan M.
    Mears, J. Gregory
    Alobeid, Bachir
    Gaglio, Paul J.
    LIVER TRANSPLANTATION, 2007, 13 (11) : 1589 - 1592
  • [24] Real-world experience in treatment of donor-derived Hepatitis C virus in kidney transplant recipients with delayed initiation, shortened course glecaprevir/pibrentasvir versus standard of care
    Papanikolla, Johanna
    McGowan, Melissa
    Chunduru, Mythili
    Winters, Holli
    Pesavento, Todd
    Smith, Rachel
    Singh, Navdeep
    Wellner, Michael
    Sobotka, Lindsay
    Nolan, Annelise
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (06)
  • [25] Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients
    Moeller, C. M.
    Valledor, A. Fernandez
    Oren, D.
    Rahman, A.
    Rubinstein, G.
    Rahman, S.
    Lee, C.
    Baranowska, J.
    Regan, M.
    Mehlman, Y.
    Lotan, D.
    DeFilippis, E. M.
    Theodoropoulos, K.
    Fried, J.
    Topkara, V.
    Majure, D.
    Colombo, P.
    Raikhelkar, J.
    Yuzefpolskaya, M.
    Clerkin, K.
    Latif, F.
    Sayer, G. T.
    Uriel, N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S58 - S58
123